New medicine authority announces plans to clear inherited backlog
Regulatory body was confident of clearing applications of new medicines licensing within two years.
Read More » New medicine authority announces plans to clear inherited backlog
Medicines Control Council
Op-ed: New health product regulatory authority launched
The South African Health Products Regulatory Authority shows promise for more efficient review and approval of medical devices and medicines, writes PATH's Yolanda Moyo.
Read More » Op-ed: New health product regulatory authority launched
Generic applications flood the MCC
The Medicine Control Council should limit generic applications to seven per innovator medicine to cut the backlog that is blocking cheaper, better drugs from entering the SA market. By Henry Leng
Read More » Generic applications flood the MCC
Litigation threat may prompt access to cheaper DR-TB drug
South Africa may finally allow access to a cheaper form of the drug-resistant tuberculosis (DR-TB) drug linezolid following the lodging of a high court case.
Read More » Litigation threat may prompt access to cheaper DR-TB drug
Provinces delay on Nevirapine research
Concerns around the efficacy of the drug Nevirapine in preventing mother-to-child transmission of HIV causes delays in provinces responding to an October 1 deadline for identifying their own sites for testing. KERRY CULLINAN reports.
Read More » Provinces delay on Nevirapine research